ATAD2 Recombinant Antibody, FITC Conjugated
Product Specifications
Background
May be a transcriptional coactivator of the nuclear receptor ESR1 required to induce the expression of a subset of estradiol target genes, such as CCND1, MYC and E2F1. May play a role in the recruitment or occupancy of CREBBP at some ESR1 target gene promoters. May be required for histone hyperacetylation. Involved in the estrogen-induced cell proliferation and cell cycle progression of breast cancer cells.
Synonyms
ANCCA; Atad2; CT137; L16; PRO2000.
Gene ID
29028
Swiss Prot
Q6PL18
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human
Target
ATAD2
Clonality
Recombinant
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human ATAD2
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
29028
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
037178-Biotin 200 µL
JAK2, ID (JAK2, Tyrosine-protein kinase JAK2, Janus kinase 2) (Biotin) discontinued
Sign In for Pricing
View Details